| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Starks Daniel J is a Director at Abbott Laboratories. Recent SEC Form 4 filings include 63 buys and 8 sells.
Estimated insider holdings value: $569.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | ABT Abbott Laboratories | Director | Buy | 10,000 | $92.65 | $926,537.00 | +0.1% | - | - | |
| Feb 4, 2026 | ABT Abbott Laboratories | Director | Buy | 10,000 | $108.73 | $1,087,331.40 | - | -19.4% | - | |
| Oct 26, 2023 | ABT Abbott Laboratories | Director | Sell | 50,000 | $94.05 | $4,702,526.31 | -0.4% | +17.9% | +21.5% | |
| Jul 27, 2023 | ABT Abbott Laboratories | Director | Sell | 50,000 | $113.76 | $5,688,188.99 | -0.4% | -16.9% | -6.6% | |
| May 2, 2023 | ABT Abbott Laboratories | Director | Sell | 50,000 | $111.02 | $5,551,192.56 | -0.4% | -0.2% | -4.7% | |
| Oct 27, 2022 | ABT Abbott Laboratories | Director | Sell | 50,000 | $97.46 | $4,872,932.14 | -0.4% | +14.5% | -4.2% | |
| Feb 27, 2018 | ABT Abbott Laboratories | Director | Buy | 29,554 | $60.77 | $1,795,900.97 | - | - | - | |
| Feb 27, 2018 | ABT Abbott Laboratories | Director | Buy | 400 | $60.87 | $24,348.00 | - | - | - | |
| Feb 27, 2018 | ABT Abbott Laboratories | Director | Buy | 40,037 | $60.67 | $2,429,236.87 | - | - | - |